ArticleJugan geon-gang gwa jilbyeong2026
Introduction to the Revised Standard Operating Procedures of the Institutional Review Board at the Korea Disease Control and Prevention Agency.
Article in Jugan geon-gang gwa jilbyeong, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To introduce the revised standard operating procedures (SOPs) of the Korea Disease Control and Prevention Agency (KDCA) Institutional Review Board (IRB) and provide practical guidance to support researchers in complying with bioethics regulations and efficiently submitting review applications. Methods: Based on the Bioethics and Safety Act and its enforcement regulations, we systematically organized the key contents of the revised SOPs, including IRB composition, review types and procedures, required documents, and important considerations for researchers. Results: The KDCA IRB played a crucial role in reviewing the research protocols before study implementation to ensure the protection of research participants' rights and welfare as the highest priority. The 2025 revised guidelines systematically specify the IRB composition and authority, clarify review types and procedures, and establish a Data Subcommittee to address ethical issues in big data and artificial intelligence research. Three types of reviews were conducted based on the risk level and characteristics of the research: regular, expedited, and exempt reviews. All the review processes were integrated using the e-IRB system. Conclusions: The revised SOPs incorporated additional provisions for the systematic operation of the KDCA IRB and included detailed practical information to assist researchers in submitting and proceeding with IRB applications. This establishes a foundation for supporting researchers' compliance with bioethics regulations and effectively responding to the evolving research environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.